Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALMATICA

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 31
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 32
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

HANGZHOU ZHONGMEI

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 32
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

ALKEM

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 31
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 20, 2023, 11:40 UTC
  • 33
  • 0 comments

FDA approve ABACAVIR SULFATE; LAMIVUDINE

Comment Full text

ASTELLAS

  • FDA Approval
  • April 19, 2023, 20:21 UTC
  • 34
  • 0 comments

FDA approve ENFORTUMAB VEDOTIN-EJFV

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 33
  • 0 comments

FDA approve VALACYCLOVIR HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 33
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

AMGEN

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 33
  • 0 comments

FDA approve FILGRASTIM

Comment Full text

DAIICHI SANKYO INC

  • FDA Approval
  • April 19, 2023, 11:43 UTC
  • 33
  • 0 comments

FDA approve PEXIDARTINIB HYDROCHLORIDE

Comment Full text
  • Previous
  • 838
  • 839
  • 840
  • 841
  • 842
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243084)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin